Skip to main content
. 2022 Oct-Dec;14(4):75–83. doi: 10.32607/actanaturae.11753

Fig. 5.

Fig. 5

Analysis of the overall survival of GC patients depending on the PU.1, CD163, and CD20 content in the tumor stroma